Regulation of Candida albicans growth and adhesion by saliva

Journal of Laboratory and Clinical Medicine

Volumn 136, Issue 1, 2000, Pages 66-73

  Ueta, Eisaku ^a   Tanida, Toyohiro ^a   Doi, Sayoko ^a   Osaki, Tokio ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ALBICANS;

EID: 0033796962     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.107304     Document Type: Article

References (52)

1. Treatment of fungal infections in neutropenic children
2. Diagnosis and prevention of fungal infection in the immunocompromised patient
3. Antifungal prophylaxis in immunocompromised hosts
4. Early infections after autologous transplantation for haematological malignancies
5. Opportunistic infections among cancer patients. A ten-year autopsy study
6. Bacterial and fungal infection in acute liver failure
7. Fungal disease in the immunocompromised host
8. Options for the management of mucosal candidiasis in patients with AIDS and HIV infection
9. Antifungal drug resistance in pathogenic fungi
10. Severe mycosis factors with fungus and host
11. In vitro, Candida albicans releases the immune modulator adenosine and a second, high-molecular weight agent that blocks neutrophil killing
12. Role of macrophages in the candidacidal activity of liposomal amphotericin B
13. A prospective study of oral lesions and their predictive value for progression of HIV disease
14. Epidemiology of visceral mycoses: Analysis of data in annual of the pathological autopsy cases in Japan
15. The importance of oral health in the older patient
16. Cellular elements in the resistance to Candida infection in mice. Contribution of T lymphocytes and phagocytes at various stages of infection
17. Neutrophil migration into the gingival sulcus is associated with transepithelial gradients of interleukin-8 and ICAM-1
18. Distribution of macrophage lineage cells in rat gingival tissue after topical application of lipopolysaccharide: An immunohistochemical study using monoclonal antibodies: OX6, ED1 and ED2
19. Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy
20. In vitro susceptibility of Candida species to lactoferrin
21. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans
22. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations
23. Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death
24. The relationship between salivary histatin levels and oral yeast carriage
25. Causes and consequences of hyposalivation
26. Salivary gland function and aging: A model for studying the interaction of aging and systemic disease
27. Aging and saliva: A review of the literature
28. Denture stomatitis in the elderly
29. Oral candidosis in elderly in longterm hospital care
30. Response and specificity of antibodies for Candida albicans
31. The adhesion of the yeast Candida albicans to epithelial cells of human origin in vitro
32. The pathophysiology of glossal pain in patients with iron deficiency and anemia
33. A new method for isolation of salivary neutrophils and determination of their functional activity
34. Candida infections: An overview
35. Fungal infections of the small and large intestine
36. Pathogenesis of Candida infections
37. Oropharyngeal candidosis in the older patient
38. Surgical management of necrotizing Candida esophagitis
39. Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: An exploratory study
40. The usefulness of routine screening for salivary secretory component
41. Cumulative correlations of lysozyme, lactoferrin, peroxidase, s-IgA, amylase, and total protein concentrations with adherence of oral Viridans streptococci to microplates coated with human saliva
42. Levels of human defensin-1, an antimicrobial peptide, in saliva of patients with oral inflammation
43. Gustatory impairment and salivary gland pathophysiology in relation to oral cancer treatment
44. Prevalence, density, and manifestations of oral Candida albicans in patient with Sjogren's syndrome
45. - co-transport in the rabbit submandibular gland
46. The covalent linkage of secretory component to IgA. Structure of sIgA
47. The effect of secretory immunoglobulin A on the in vitro adherence of the yeast Candida albicans to human oral epithelial cells
48. Iron binding proteins in milk and resistance to Escherichia coli infection in infants
49. Anti-Candida activity of induced transferrin in mice immunized with inactivated Candida albicans
50. Neutrophil-mediated cytotoxicity induced by secretory IgA
51. Augmented inhibition of growth of Candida albicans by neutrophils in the presence of lactoferrin
52. Identification of the bactericidal domain of lactoferrin